| Nov 21 |
Novocure secures FDA approval for add-ons to brain cancer treatment wearable
|
| Nov 21 |
Novocure gets FDA approval for its HFE transducer arrays for glioblastoma treatment
|
| Nov 21 |
Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
|
| Nov 21 |
FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
|
| Oct 31 |
NovoCure’s Strong Q3 and Leadership Changes in 2024
|
| Oct 31 |
NovoCure Ltd (NVCR) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ...
|
| Oct 31 |
NovoCure (NVCR) Q3 2024 Earnings Call Transcript
|
| Oct 30 |
NovoCure Limited (NVCR) Q3 2024 Earnings Conference Call Transcript
|
| Oct 30 |
NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates
|
| Oct 30 |
Novocure appoints Moderna's exec Christoph Brackmann as CFO
|
